Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 14;58(1):143-161.e8.
doi: 10.1016/j.immuni.2024.12.003. Epub 2024 Dec 27.

Splenic fibroblasts control marginal zone B cell movement and function via two distinct Notch2-dependent regulatory programs

Affiliations

Splenic fibroblasts control marginal zone B cell movement and function via two distinct Notch2-dependent regulatory programs

Anneka Allman et al. Immunity. .

Abstract

Innate-like splenic marginal zone (MZ) B (MZB) cells play unique roles in immunity due to their rapid responsiveness to blood-borne microbes. How MZB cells integrate cell-extrinsic and -intrinsic processes to achieve accelerated responsiveness is unclear. We found that Delta-like1 (Dll1) Notch ligands in splenic fibroblasts regulated MZB cell pool size, migration, and function. Dll1 could not be replaced by the alternative Notch ligand Dll4. Dll1-Notch2 signaling regulated a Myc-dependent gene expression program fostering cell growth and a Myc-independent program controlling cell-movement regulators such as sphingosine-1 phosphate receptor 1 (S1PR1). S1pr1-deficient B cells experienced Notch signaling within B cell follicles without entering the MZ and were retained in the spleen upon Notch deprivation. Key elements of the mouse B cell Notch regulome were preserved in subsets of human memory B cells and B cell lymphomas. Thus, specialized niches program the poised state and patrolling behavior of MZB cells via conserved Myc-dependent and Myc-independent Notch2-regulated mechanisms.

Keywords: B cells; Notch; chemotaxis; fibroblastic reticular cells; marginal zone; spleen.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests S.K. is currently employed by Century Therapeutics; L.C. by Interius BioTherapeutics; D.G.A. by Aro Biotherapeutics; and C.W.S by Gilead Sciences. L.M. is a current and C.W.S. a former employee of Genentech. I.M. has received research funding from Genentech and Regeneron and is a member of Garuda Therapeutics’s scientific advisory board.

References

    1. Martin F, Oliver AM, and Kearney JF (2001). Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14, 617–629. - PubMed
    1. Oliver AM, Martin F, and Kearney JF (1999). IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J Immunol 162, 7198–7207. - PubMed
    1. Oliver AM, Martin F, Gartland GL, Carter RH, and Kearney JF (1997). Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur J Immunol 27, 2366–2374. 10.1002/eji.1830270935. - DOI - PubMed
    1. Gaudette BT, Roman CJ, Ochoa TA, Gomez Atria D, Jones DD, Siebel CW, Maillard I, and Allman D (2021). Resting innate-like B cells leverage sustained Notch2/mTORC1 signaling to achieve rapid and mitosis-independent plasma cell differentiation. J Clin Invest 131. 10.1172/JCI151975. - DOI - PMC - PubMed
    1. Gaudette BT, Jones DD, Bortnick A, Argon Y, and Allman D (2020). mTORC1 coordinates an immediate unfolded protein response-related transcriptome in activated B cells preceding antibody secretion. Nat Commun 11, 723. 10.1038/s41467-019-14032-1. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources